Total₹1800
| Wiki Information | Abciximab API ManufacturersAbciximab is the Fab antibody fragment of chimeric human-murine monoclonal antibody 7E3. This medication inhibits platelet aggregation by reversibly binding to platelet IIb/IIIa receptors, which in turn results in steric hindrance. |
| Indication & Benefits | Prevention of cardiac ischemic complications in patients undergoing PCI |
| How To Use | |
| Deficiency | |
| Recommended For Better | |
| Pregnancy Warning | |
| Side Effects | |
| Disclaimer | Information provided on this site is intended for use only for a particular country. Products protected under valid patents are not manufactured, offered, or supplied by ENOMARK. The product information provided on this site is for general information purposes only and does not construe as commercial or approved product information. Consumers should not construe any information herein as medical advice or as a substitute, The Company and its affiliates accept no responsibility for the reliance on or use of any information contained herein. The reader understands and agrees to the foregoing as well as all terms and conditions of the Legal Statement. |
| Products |